These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 39129828)

  • 1. CircEZH2 promotes gallbladder cancer progression and lipid metabolism reprogramming through the miR-556-5p/SCD1 axis.
    Tong H; Yu X; Zhou D; Shen Z; Chen J; Si Y; Zhang L; Lu B; Yu J; Wang S; Tang Z
    iScience; 2024 Aug; 27(8):110428. PubMed ID: 39129828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CircEZH2/miR-133b/IGF2BP2 aggravates colorectal cancer progression via enhancing the stability of m
    Yao B; Zhang Q; Yang Z; An F; Nie H; Wang H; Yang C; Sun J; Chen K; Zhou J; Bai B; Gu S; Zhao W; Zhan Q
    Mol Cancer; 2022 Jun; 21(1):140. PubMed ID: 35773744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lidocaine inhibits glioma cell proliferation, migration and invasion by modulating the circEZH2/miR-181b-5p pathway.
    Wen J; Li X; Ding Y; Zheng S; Xiao Y
    Neuroreport; 2021 Jan; 32(1):52-60. PubMed ID: 33252475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The FUS/circEZH2/KLF5/ feedback loop contributes to CXCR4-induced liver metastasis of breast cancer by enhancing epithelial-mesenchymal transition.
    Liu P; Wang Z; Ou X; Wu P; Zhang Y; Wu S; Xiao X; Li Y; Ye F; Tang H
    Mol Cancer; 2022 Oct; 21(1):198. PubMed ID: 36224562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DGCR5 Promotes Gallbladder Cancer by Sponging MiR-3619-5p via MEK/ERK1/2 and JNK/p38 MAPK Pathways.
    Liu S; Chu B; Cai C; Wu X; Yao W; Wu Z; Yang Z; Li F; Liu Y; Dong P; Gong W
    J Cancer; 2020; 11(18):5466-5477. PubMed ID: 32742494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-29c-5p suppresses gallbladder carcinoma progression by directly targeting CPEB4 and inhibiting the MAPK pathway.
    Shu YJ; Bao RF; Jiang L; Wang Z; Wang XA; Zhang F; Liang HB; Li HF; Ye YY; Xiang SS; Weng H; Wu XS; Li ML; Hu YP; Lu W; Zhang YJ; Zhu J; Dong P; Liu YB
    Cell Death Differ; 2017 Mar; 24(3):445-457. PubMed ID: 28060377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CircPVT1 promotes gallbladder cancer growth by sponging miR-339-3p and regulates MCL-1 expression.
    Wang S; Su TT; Tong H; Shi W; Ma F; Quan Z
    Cell Death Discov; 2021 Jul; 7(1):191. PubMed ID: 34312371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exosomal long non-coding RNA TRPM2-AS promotes angiogenesis in gallbladder cancer through interacting with PABPC1 to activate NOTCH1 signaling pathway.
    He Z; Zhong Y; Regmi P; Lv T; Ma W; Wang J; Liu F; Yang S; Zhong Y; Zhou R; Jin Y; Cheng N; Shi Y; Hu H; Li F
    Mol Cancer; 2024 Mar; 23(1):65. PubMed ID: 38532427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CircTP63 promotes cell proliferation and invasion by regulating EZH2 via sponging miR-217 in gallbladder cancer.
    Wang S; Tong H; Su T; Zhou D; Shi W; Tang Z; Quan Z
    Cancer Cell Int; 2021 Nov; 21(1):608. PubMed ID: 34789260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LDHA is a direct target of miR-30d-5p and contributes to aggressive progression of gallbladder carcinoma.
    He Y; Chen X; Yu Y; Li J; Hu Q; Xue C; Chen J; Shen S; Luo Y; Ren F; Li C; Bao J; Yan J; Qian G; Ren Z; Sun R; Cui G
    Mol Carcinog; 2018 Jun; 57(6):772-783. PubMed ID: 29569755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IGF2BP3 promotes progression of gallbladder carcinoma by stabilizing KLK5 mRNA in N
    Zhang J; Yang K; Bu J; Yan J; Hu X; Liu K; Gao S; Tang S; Gao L; Chen W
    Front Oncol; 2022; 12():1035871. PubMed ID: 36313631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-143-5p Deficiency Triggers EMT and Metastasis by Targeting HIF-1α in Gallbladder Cancer.
    He M; Zhan M; Chen W; Xu S; Long M; Shen H; Shi Y; Liu Q; Mohan M; Wang J
    Cell Physiol Biochem; 2017; 42(5):2078-2092. PubMed ID: 28803245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-139-5p is associated with poor prognosis and regulates glycolysis by repressing PKM2 in gallbladder carcinoma.
    Chen J; Yu Y; Chen X; He Y; Hu Q; Li H; Han Q; Ren F; Li J; Li C; Bao J; Ren Z; Duan Z; Cui G; Sun R
    Cell Prolif; 2018 Dec; 51(6):e12510. PubMed ID: 30105813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA H19 contributes to gallbladder cancer cell proliferation by modulated miR-194-5p targeting AKT2.
    Wang SH; Wu XC; Zhang MD; Weng MZ; Zhou D; Quan ZW
    Tumour Biol; 2016 Jul; 37(7):9721-30. PubMed ID: 26803515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-4733-5p promotes gallbladder carcinoma progression via directly targeting kruppel like factor 7.
    Hu X; Zhang J; Bu J; Yang K; Xu S; Pan M; Xiang D; Chen W
    Bioengineered; 2022 Apr; 13(4):10691-10706. PubMed ID: 35443866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. YTHDF2 promotes gallbladder cancer progression and gemcitabine resistance via m6A-dependent DAPK3 degradation.
    Bai X; Chen J; Zhang W; Zhou S; Dong L; Huang J; He X
    Cancer Sci; 2023 Nov; 114(11):4299-4313. PubMed ID: 37700438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNA PVT1 promoted gallbladder cancer proliferation by epigenetically suppressing miR-18b-5p via DNA methylation.
    Jin L; Cai Q; Wang S; Wang S; Wang J; Quan Z
    Cell Death Dis; 2020 Oct; 11(10):871. PubMed ID: 33067424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of miR-146b-5p in tissues as a novel biomarker for prognosis of gallbladder carcinoma.
    Lv YP; Shi W; Liu HX; Kong XJ; Dai DL
    Eur Rev Med Pharmacol Sci; 2017 Feb; 21(3):518-522. PubMed ID: 28239818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circβ-catenin promotes tumor growth and Warburg effect of gallbladder cancer by regulating STMN1 expression.
    Wang S; Su T; Tong H; Zhou D; Ma F; Ding J; Hao Y; Shi W; Quan Z
    Cell Death Discov; 2021 Sep; 7(1):233. PubMed ID: 34489401
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Zhu H; Chen Z; Yu J; Wu J; Zhuo X; Chen Q; Liang Y; Li G; Wan Y
    Ann Transl Med; 2022 Aug; 10(16):893. PubMed ID: 36111048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.